Zoetis (ZTS) Asset Utilization Ratio (2013 - 2026)
Zoetis (ZTS) posted quarterly Asset Utilization Ratio of 0.62 for Q1 2026, down 5.21% year-over-year from 0.65 in Q1 2025, and up 0.69% quarter-over-quarter from 0.62 in Q4 2025.
Zoetis (ZTS) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Asset Utilization Ratio for 14 consecutive years, with 0.62 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 5.21% year-over-year to 0.62; the TTM figure through Mar 2026 stood at 0.62 (down 5.21% YoY), while the FY2025 annual figure was 0.64, down 1.87% from the prior year.
- Asset Utilization Ratio improved to 0.62 in Q1 2026 per ZTS's latest filing, from 0.62 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.66 in Q2 2025 and bottomed at 0.56 in Q1 2023.
- Historically, Asset Utilization Ratio has averaged 0.61 across 5 years, with a median of 0.61 in 2024.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio rose 11.1% — and 2026, when it slipped 5.21%.
- Zoetis' Asset Utilization Ratio stood at 0.57 in 2022, then rose by 6.51% to 0.6 in 2023, then increased by 7.71% to 0.65 in 2024, then fell by 4.92% to 0.62 in 2025, then increased by 0.69% to 0.62 in 2026.
- Business Quant data shows ZTS's Asset Utilization Ratio at 0.62 in Q1 2026, 0.62 in Q4 2025, and 0.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.63 |
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 0.65 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.64 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.60 |
| Jun 30, 2023 | 0.60 |
| Mar 31, 2023 | 0.56 |
| Dec 31, 2022 | 0.57 |
| Sep 30, 2022 | 0.58 |
| Jun 30, 2022 | 0.58 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.56 |
| Sep 30, 2021 | 0.55 |